Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. (DYN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DYN · as of Jun 8, 2026
Key Statistics
Explore Dyne Therapeutics, Inc. Data
dyn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 85.7%
The DYN analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $37.40, representing +119.48% upside from the current price of $17.04.
Competitors & Peers
dyn competitorsDYN
AAPG
APGE
CELC
CGON
CNTAStock Performance
Full HistoryAbout Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops v…
what is dyne therapeutics, inc. · dyn stock overview · dyne therapeutics, inc. company profile · who is dyne therapeutics, inc. ceo · dyn NASDAQ · dyne therapeutics, inc. headquarters · dyne therapeutics, inc. business segments
About Stock Overview & Key Data
Dyne Therapeutics, Inc. (DYN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 17, 2020. As of the latest trading session, DYN stock price is $17.04, with a market capitalization of $2.8B. The stock has returned +18.33% over the past 12 months and -12.88% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Dyne Therapeutics, Inc. stock is Buy, with an average 12-month price target of $37.40. In fiscal year 2025, Dyne Therapeutics, Inc. reported revenue of — and net income of -$446.2M. For detailed data — including Dyne Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dyne Therapeutics, Inc. (DYN) stock price is $17.04. The stock is traded on NASDAQ under the ticker symbol DYN. The 52-week range is $8.06 – $25.00.